Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis DCAL

Max Ratio

Dividend Yield

0.090 %

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History DCAL

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 0.090 %
Consecutive Years 0
Forward Annual Dividend 0.20 INR
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 09/12/2019

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth DCAL

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin DCAL

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income DCAL

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM DCAL

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio DCAL

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Dishman Carbogen Amcis Limited DCAL

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself DCAL

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 27.13
Forward PE
Enterprise Value Revenue 2.10
Price Sales TTM 1.35
Enterprise Value EBITDA 9.29
Price Book MRQ 0.59

Dishman Carbogen Amcis Limited Dividends: – Yield, History, Payment Schedule

DCAL
Current price
222.80 INR -4.23 INR (-1.86%)
Last closed 228.56 INR
Company imdcal.com
ISIN INE385W01011
Sector Healthcare
Industry Biotechnology
Exchange National Stock Exchange of India
Capitalization 37 027 896 725 INR
Yield for 12 month -17.40 %
1Y
3Y
5Y
10Y
15Y
DCAL
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+27 051 419 797 INR

Last Year

+26 096 364 536 INR

Current Quarter

+6 511 196 480 INR

Last Quarter

+7 063 897 366 INR

Current Year

+22 046 682 719 INR

Last Year

+18 402 846 961 INR

Current Quarter

+2 007 980 579 INR

Last Quarter

+6 085 297 432 INR
EBITDA 5 311 615 923 INR
Operating Margin TTM 9.92 %
Price to Earnings 27.13
Return On Assets TTM 1.67 %
PEG Ratio
Return On Equity TTM 2.25 %
Wall Street Target Price 14 841.01 INR
Revenue TTM 27 529 096 792 INR
Book Value 404.72 INR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -17.30 %
Dividend Yield 0.090 %
Gross Profit TTM 22 415 914 664 INR
Earnings per share 8.68 INR
Diluted Eps TTM 8.68 INR
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY 97.20 %
Profit Margin 4.94 %

Technical Indicators DCAL

For 52 Weeks

177.58 INR 321.20 INR
50 Day MA 271.55 INR
Shares Short Prior Month
200 Day MA 247.59 INR
Short Ratio
Shares Short
Short Percent